Her-2 Positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Her-2 Positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial assessing ruxolitinib in combination with trastuzumab for metastatic HER2-positive breast cancer has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer [Phase 2]
Phase 2 study of trastuzumab with etoposide in HER-2 positive metastatic breast cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS withdrawal · 2017-05-09Clinical Trial Update: AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of AUY922 in combination with lapatinib and letrozole for ER-positive, HER2-positive advanced breast cancer has been withd…